PRMT5 mutations are endemic in cancer cells, suggesting that its function is required for the maintenance of genomic stability (Rasheed, Bouley et al. 2023, Al-Marrawi, Petreaca et al. 2025). The gene discussed is PRMT5; the disease is cancer.